CA1187825A - Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease - Google Patents

Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease

Info

Publication number
CA1187825A
CA1187825A CA000428433A CA428433A CA1187825A CA 1187825 A CA1187825 A CA 1187825A CA 000428433 A CA000428433 A CA 000428433A CA 428433 A CA428433 A CA 428433A CA 1187825 A CA1187825 A CA 1187825A
Authority
CA
Canada
Prior art keywords
protein
complex
character
laughed
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000428433A
Other languages
English (en)
French (fr)
Inventor
Robert D. Rosenberg
Marcel Jozefowicz
Christine Fougnot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat à l'Énergie Atomique et Aux Énergies Alternatives
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Application granted granted Critical
Publication of CA1187825A publication Critical patent/CA1187825A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
CA000428433A 1982-05-19 1983-05-18 Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease Expired CA1187825A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8208779A FR2527222A1 (fr) 1982-05-19 1982-05-19 Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease
FR8208779 1982-05-19

Publications (1)

Publication Number Publication Date
CA1187825A true CA1187825A (fr) 1985-05-28

Family

ID=9274202

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000428433A Expired CA1187825A (fr) 1982-05-19 1983-05-18 Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease

Country Status (6)

Country Link
US (1) US4945054A (cg-RX-API-DMAC10.html)
EP (1) EP0094892B1 (cg-RX-API-DMAC10.html)
JP (1) JPS58212785A (cg-RX-API-DMAC10.html)
CA (1) CA1187825A (cg-RX-API-DMAC10.html)
DE (1) DE3361689D1 (cg-RX-API-DMAC10.html)
FR (1) FR2527222A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US20050214457A1 (en) * 2004-03-29 2005-09-29 Applied Materials, Inc. Deposition of low dielectric constant films by N2O addition
CN101307093B (zh) * 2007-05-14 2012-01-11 上海水产大学 从鲨鱼皮分离纯化生物医药用胶原蛋白的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463729A (fr) * 1965-02-24 1966-12-23 Rohm & Haas Enrichissement et éventuellement séparation d'un composé organique par des techniques d'adsorption
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3902964A (en) * 1971-12-13 1975-09-02 U S Medical Research And Dev I Method of and apparatus for chemically separating plasma or serum from formed elements of blood
DE2406971B2 (de) * 1974-02-14 1979-08-09 Behringwerke Ag, 3550 Marburg Verfahren zur Gewinnung eines polyvalenten Proteinasen-Inhibitors
US3928587A (en) * 1974-08-16 1975-12-23 Philip Nicholas Sawyer Method of conditioning vascular systems by administering 3,5 dichloroaspirin and method of evaluating pharmaceutical compounds
FR2461724A1 (fr) * 1979-07-20 1981-02-06 Christine Fougnot Polymeres substitues par des groupes leur conferant des proprietes anti-coagulantes et leur procede de preparation, objets constitues par et/ou comprenant lesdits polymeres et leurs procedes de fabrication, application desdits objets en chirurgie et en medecine, et compositions pharmaceutiques contenant lesdits polymeres substitues
JP2528471B2 (ja) * 1987-06-22 1996-08-28 出光興産株式会社 ジクロロシラン類の製造方法
DE20022020U1 (de) * 2000-12-28 2001-11-08 Trw Automotive Safety Sys Gmbh Gassackmodul

Also Published As

Publication number Publication date
DE3361689D1 (en) 1986-02-13
FR2527222A1 (fr) 1983-11-25
EP0094892B1 (fr) 1986-01-02
FR2527222B1 (cg-RX-API-DMAC10.html) 1985-01-11
US4945054A (en) 1990-07-31
EP0094892A1 (fr) 1983-11-23
JPS58212785A (ja) 1983-12-10
JPH0446960B2 (cg-RX-API-DMAC10.html) 1992-07-31

Similar Documents

Publication Publication Date Title
EP0317376B1 (fr) Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
BE1004178A3 (fr) Procede de preparation a l'echelle industrielle d'un concentre de facteur von willebrand humain standardise, de tres haute purete, approprie a un usage therapeutique.
EP1385886B1 (fr) Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
CA2073734C (fr) Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique
EP0416983B1 (fr) Procédé de préparation de concentré du complexe Facteur VIII-facteur von Willebrand de la coagulation sanguine à partir de plasma total
US7531513B2 (en) Therapeutic preparation of very high purity FVIIa and method for obtaining same
CA1157375A (fr) Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
EP0512883B1 (fr) Procédé de préparation d'un concentré de facteur XI de la coagulation sanguine à haute activité spécifique, approprié à un usage thérapeutique
CA1154671A (fr) Separation d'un activateur tissulaire du plasminogene
EP0402205A1 (fr) Procédé de préparation de solutions d'albumine purifiée
WO2008068455A1 (en) Protein purification
KR20010034309A (ko) 피브리노겐 정제
JPS6351335A (ja) 肥満細胞脱顆粒抑制剤
FR2527222A1 (fr) Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease
WO1986006963A1 (fr) Procede de preparation de gamma-globulines administrees par voie intraveineuse et gamma-globulines obtenues
CA2154231C (fr) Procede de preparation d'un concentre d'inhibiteur de la c1-esterase (c1-inh), et concentre obtenu, a usage therapeutique
EP0383645B1 (fr) Procédé de fabrication du facteur antihémophilique (FVIIIc) ayant une très haute pureté.
EP0397571A1 (fr) Utilisation du caséinoglycopeptide k pour la fabrication d'une composition, notamment d'un médicament, pour la prévention et le traitement des thromboses
FR2489838A1 (fr) Endoproteinase-lys-c provenant de bacteries, sa preparation et son utilisation
JPH0359078B2 (cg-RX-API-DMAC10.html)
AU781717B2 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or mixture of both proteins by means of ion-exchange chromatography
EP0472711A1 (fr) Procede de preparation d'une solution concentree de facteur viii
JPH0211600A (ja) 尿dafの製造方法

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry